Publications by authors named "Alejandra Arredondo"
Support Care Cancer
March 2022
Article Synopsis
- The study aims to evaluate and compare the outcomes and costs associated with outpatient (OP) versus inpatient (IP) ifosfamide therapy for cancer treatment.
- A review of 86 patient charts showed that OP therapy had fewer severe side effects and led to a significant reduction in hospital stays and costs, amounting to $2,103,921 in savings.
- The findings suggest that OP administration of ifosfamide is safe, well-tolerated, and can effectively transition chemotherapy treatments, especially useful during challenging times like the COVID pandemic.
